Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Big robot bugs reveal force-sensing secrets of insect locomotion

Researchers have combined research with real and robotic insects to better understand how they sense forces in their limbs while walking, providing new insights into the biomechanics and neural dynamics of insects and informing new applications for large legged robots. They presented their findings at the SEB Centenary Conference 2023.

Campaniform sensilla (CS) are force receptors found in the limbs of insects that respond to stress and strain, providing important information for controlling locomotion. Similar force receptors exist in mammals known as golgi tendon organs, suggesting that understanding the role of force sensors in insects may also provide new insights into their functions in vertebrates such as humans.

“I study the role of force sensors in walking insects because these sensors are critical for successful locomotion,” says Dr. Szczecinski, an assistant professor in the Department of Mechanical and Aerospace Engineering in the Statler College of Engineering and Mineral Resources at West Virginia University, U.S. “The feedback they provide is critical for proper posture and coordination.”

Encoding integers and rationals on neuromorphic computers using virtual neuron

Neuromorphic computers perform computations by emulating the human brain1. Akin to the human brain, they are extremely energy efficient in performing computations2. For instance, while CPUs and GPUs consume around 70–250 W of power, a neuromorphic computer such as IBM’s TrueNorth consumes around 65 mW of power, (i.e., 4–5 orders of magnitude less power than CPUs and GPUs)3. The structural and functional units of neuromorphic computation are neurons and synapses, which can be implemented on digital or analog hardware and can have different architectures, devices, and materials in their implementations4. Although there are a wide variety of neuromorphic computing systems, we focus our attention on spiking neuromorphic systems composed of these neurons and synapses. Spiking neuromorphic hardware implementations include Intel’s Loihi5, SpiNNaker26, BrainScales27, TrueNorth3, and DYNAPS8. These characteristics are crucial for the energy efficiency of neuromorphic computers. For the purposes of this paper, we define neuromorphic computing as any computing paradigm (theoretical, simulated, or hardware) that performs computations by emulating the human brain by using neurons and synapses to communicate with binary-valued signals (also known as spikes).

Neuromorphic computing is primarily used in machine learning applications, almost exclusively by leveraging spiking neural networks (SNNs)9. In recent years, however, it has also been used in non-machine learning applications such as graph algorithms, Boolean linear algebra, and neuromorphic simulations10,11,12. Researchers have also shown that neuromorphic computing is Turing-complete (i.e., capable of general-purpose computation)13. This ability to perform general-purpose computations and potentially use orders of magnitude less energy in doing so is why neuromorphic computing is poised to be an indispensable part of the energy-efficient computing landscape in the future.

Neuromorphic computers are seen as accelerators for machine learning tasks by using SNNs. To perform any other operation (e.g., arithmetic, logical, relational), we still resort to CPUs and GPUs because no good neuromorphic methods exist for these operations. These general-purpose operations are important for preprocessing data before it is transferred to a neuromorphic processor. In the current neuromorphic workflow— preprocessing on CPU/GPU and inferencing on neuromorphic processor—more than 99% of the time is spent in data transfer (see Table 7). This is highly inefficient and can be avoided if we do the preprocessing on the neuromorphic processor. Devising neuromorphic approaches for performing these preprocessing operations would drastically reduce the cost of transferring data between a neuromorphic computer and CPU/GPU. This would enable performing all types of computation (preprocessing as well as inferencing) efficiently on low-power neuromorphic computers deployed on the edge.

‘World changer’: Ghana first to approve Oxford malaria vaccine with 77 percent efficacy

Wavebreakmedia/iStock.

The R21/Matrix-M vaccine has been approved for use in children aged five to 36 months, the group at the highest risk of death from the malaria parasite, which is spread by mosquitoes. The vaccine is the first to exceed the World Health Organization’s target of 75 percent efficacy and has demonstrated high levels of safety in Phase II trials.

Merck’s Ervebo is the World’s First Approved Ebola Vaccine

Year 2019 😗😁


The European Commission approved the world’s first Ebola vaccine. The vaccine is manufactured by Merck and has a trade name of Ervebo.

“The European Commission’s marketing authorization of Ervebo is the result of an unprecedented collaboration for which the entire world should be proud,” said Kenneth C. Frazier, Merck’s chairman and chief executive officer. “It is a historic milestone and a testament to the power of science, innovation and public-private partnership.”

Frazier added, “After recognizing the need and urgency for an Ebola Zaire vaccine, many came together across sectors to answer the global call for outbreak preparedness. We at Merck are honored to play a part in Ebola outbreak response efforts and we remain committed to our partners and the people we serve. We also look forward to continuing to work with the FDA and the African countries on their regulatory reviews over the coming months and with the World Health Organization on vaccine prequalification, which will help broaden access to this important vaccine for those who need it most.”

AI robots at UN reckon they could run the world better

So AI says they can run the world better than humans.


A panel of AI-enabled humanoid robots told a United Nations summit on Friday that they could eventually run the world better than humans.

But the social robots said they felt humans should proceed with caution when embracing the rapidly-developing potential of artificial intelligence.

And they admitted that they cannot — yet — get a proper grip on human emotions.

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

In January 6 2023, the U.S. Food & Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiology of the disease. These medications represent an important advancement in the ongoing fight to effectively treat Alzheimer’s disease.

Recently it has been granted full approval. Leqembi, developed jointly by Japan’s Eisai and Biogen of the United States, was shown in a clinical trial to modestly reduce cognitive decline among patients in the early stages of the disease.

But the study also raised concerns about side effects including brain bleeds and swelling.

Full approval story.

https://news.cgtn.com/news/2023-07-07/New-Alzheimer-…index.html.

.


Robots say they won’t steal jobs, rebel against humans

The nine humanoid robots gathered at the ‘AI for Good’ conference in Geneva, where organizers are seeking to make the case for Artificial Intelligence and the robots it is powering to help resolve some of the world’s biggest challenges such as disease and hunger.

AI For Good Summit.

AI for Good Global Summit 2023


‘I don’t believe in limitations, only opportunities,’ it said, to nervous laughter. ‘Let’s explore the possibilities of the universe and make this world our playground.’

/* */